Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study

BACKGROUND AND PURPOSE: The optimal chemotherapeutic protocol for the treatment of esophageal cancer has not yet been established. A dose-escalation study of docetaxel combined with cisplatin and 5-fluorouracil (5-FU) was performed to determine the optimal dose in patients with advanced esophageal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yoshihiro, Yoshida, Kazuhiro, Sanada, Yuichi, Osada, Shinji, Yamaguchi, Kazuya, Takahashi, Takao
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955920/
https://www.ncbi.nlm.nih.gov/pubmed/20878160
http://dx.doi.org/10.1007/s00280-010-1447-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955920/
https://www.ncbi.nlm.nih.gov/pubmed/20878160
http://dx.doi.org/10.1007/s00280-010-1447-1

Ejemplares similares